Vergleich

MIA PaCa-2 cells

ArtNr C0018002
Hersteller Addexbio
Menge One Frozen vial
Kategorie
Typ Tumour Cells
Specific against Human (Homo sapiens)
Dry ice Yes
Citations 1.Hussein, D. and Mo, H. d-delta-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells. Pancreas, 38: e124-136, 2009.
2.Reigan, P., Colucci, M. A., Siegel, D., Chilloux, A., Moody, C. J., and Ross, D. Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells. Biochemistry, 46: 5941-5950, 2007.
3.Kato, S., Shirato, K., Imaizumi, K., Toyota, H., Mizuguchi, J., Odawara, M., Che, X. F., Akiyama, S., Abe, A., and Tomoda, A. Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2. Oncol Rep, 15: 843-848, 2006.
4.Fogli, S., Nieri, P., Chicca, A., Adinolfi, B., Mariotti, V., Iacopetti, P., Breschi, M. C., and Pellegrini, S. Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism. FEBS Lett, 580: 1733-1739, 2006.
5.Roomi, M. W., Ivanov, V., Kalinovsky, T., Niedzwiecki, A., and Rath, M. Antitumor effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2. Int J Gastrointest Cancer, 35: 97-102, 2005.
6.Hashimoto, K., Farrow, B. J., and Evers, B. M. Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2. Pancreas, 28: 153-159, 2004.
ECLASS 10.1 32160890
ECLASS 11.0 32160890
UNSPSC 41106509
Lieferbar
Description
Disease:
Pancreatic carcinoma
Origin:
An established cell line from an undifferentiated human pancreatic carcinoma
Species:
Homo sapiens
Tissue:
Pancreas
Morphology:
Epithelial
Properties:
Adherent, single cells and loosely attached clusters
Cytogenic data:
Tumorigenic; Modal no. 61; hypotriploid
Patient:
Male, Caucasian, 65 yrs of age
Medium:
AddexBio-formulated DMEM (C0003-01) + 10% FBS
Subculture:
1:3 to 1:6 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C
Freezing Medium:
Complete culture medium supplemented with 5% (v/v) DMSO
Biosafety Level: I
Sterility:
Bacteria: Negative
Yeast: Negative
Mycoplasma: Negative
Pathogens:
HIV: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Protein Expression: human colony stimulating factor, subclass I (CSF-I); plasminogen activator
Isoenzymes: G6PD, B
DNA Profile (STR): Amelogenin: X CSF1PO: 10 D13S317: 12, 13 D16S539: 10, 13 D5S818: 12, 13 D7S820: 12, 13 THO1: 9, 10 TPOX: 9 vWA: 15 Mutations in MIA PaCa-2 Cells
Related cells by Organ: AR-42J cells
BxPc-3 cells
Capan-1 cells
MIA PaCa-2 cells
E3LZ10.7 cells
A10.7 cells
INS-1 cells
MIN-6 cells
Storage condition
LN2
Manufacturer - Category
Cell Lines

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: One Frozen vial
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen